Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Next Generation Diagnostic Tool May Transform Patient Outcomes

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Medical Imaging Innovation Improving Diagnostic Accuracy

The rapid evolution of high-resolution sensors and intelligent algorithmic...

Medical Device Innovation and Regulatory Strategy...

A comprehensive look at how the medical device sector is navigating the complex intersection of cutting-edge technology and increasingly stringent global regulations. The industry is currently shifting toward a more data-centric approach to compliance, where clinical validation and quality assurance are integrated into the earliest stages of product development.

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.
During the 12th Annual Scientific Sessions  of the Society for Cardiovascular Magnetic Resonance (SCMR), the world’s major international society for cardiovascular imaging, the role of perfusion imaging in clinical decision making will be refined.

During the 12th Annual Scientific Sessions  of the Society for Cardiovascular Magnetic Resonance (SCMR), the world’s major international society for cardiovascular imaging, the role of perfusion imaging in clinical decision making will be refined.

This technique allows measuring blood flow to the heart muscle with an unprecedented spatial resolution and without any ionizing radiation. Multicenter data has already suggested a superiority of this technique in comparison to methods now used on a routine basis. New data presented during the meeting further expands its role, suggesting that new techniques with faster imaging will further improve spatial resolution and enhance diagnostic accuracy.

Magnetic resonance perfusion imaging, for example, may also be used in patients after bypass surgery. This is due to its ability to discriminate areas with scar from complex flow patterns as found after surgery. Similarly, the high spatial resolution allows detecting remaining areas of reduced blood flow after therapy. These new areas for using magnetic resonance perfusion imaging expand the indications of this relatively young technique and lead to a reconsideration of the application of magnetic resonance imaging mainly as a second line technique.

“Given the amount of information we get from a single examination, ranging from the size and function of the heart, through scar tissue after myocardial infarction, to an excellent visualization of myocardial blood flow,” said Christoph Klein, MD from the German Heart Institute Berlin. “We should use magnetic resonance imaging as the premier imaging technique in a large group of patients.”

Further research is guided towards quantitative assessment of myocardial blood flow to allow doctors not only to discriminate between normal and abnormal blood flow, but also to measure the effect of therapy and to individually guide patient management.

Founded in 1994, SCMR is a professional association whose vision is to be the recognized representative and advocate for physicians, scientists and technologists who work in the field of cardiovascular magnetic resonance. SCMR endeavors to be the principal international, independent organization committed to the further development of cardiovascular magnetic resonance through education, quality control, research, and training.

Contact:
Deborah Berkowitz, SCMR
(856) 423-7222; dberkowitz@talley.com
Eike Nagel, MD, PhD
eike.nagel@kcl.ac.uk

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

Medical Imaging Innovation Improving Diagnostic Accuracy

The rapid evolution of high-resolution sensors and intelligent algorithmic...

Medical Device Innovation and Regulatory Strategy Trends

A comprehensive look at how the medical device sector is navigating the complex intersection of cutting-edge technology and increasingly stringent global regulations. The industry is currently shifting toward a more data-centric approach to compliance, where clinical validation and quality assurance are integrated into the earliest stages of product development.

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Medtronic Wins FDA Clearance for MiniMed Go Smart MDI System

Medtronic has received U.S. Food and Drug Administration (FDA)...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »